跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
TRISENOX
Authorized
STANDARD
TRISENOX
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1bd9fe10a2f05daa
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
1bd9fe10a2f05daa
Drug Approval Canada Name
TRISENOX
Product Name
TRISENOX
Status
Cancelled Post Market
Status Date
2023-04-18
Original Market Date
2020-04-16
Din
02480387
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XX27 ARSENIC TRIOXIDE
Atc Name
l 01 xx 27
Aig Number
0108756004
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
ARSENIC TRIOXIDE
12 MG / 6 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1bd9fe10a2f05daa
Type
Standard
Back to Health Canada Approvals
TRISENOX - Health Canada Drug Approval Details